Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF in breast cancer patients treated with intensive chemotherapy
NCT02944604Phase 4Completed
- Sponsor
- Peking University
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Peking University. Started Sep 2016; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT02944604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944604.